Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
T. Luchnikova (Blagoveshchensk (Amur Oblast), Russian Federation), O. Prikhodko (Blagoveshchensk (Amur Oblast), Russian Federation). Vitamin D as a marker of worsening of the course of pneumonia.. 2343

Member's Comments

No comment yet.

Related content which might interest you: Vitamin D level predicts clinical outcome in community-acquired pneumonia Source: Annual Congress 2012 - Prognosis and outcome of respiratory infections Year: 2012 Vitamin D deficiency and exacerbation frequency in COPD Source: Annual Congress 2009 - COPD: exacerbation and clinical problems Year: 2009 Vitamin D deficiency and FEV1 decline in COPD Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009 Vitamin D deficiency and COPD exacerbations: Effect of vitamin D supplementation Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015 The role of vitamin D in severe asthma Source: International Congress 2017 – Novel mechanisms in asthma Year: 2017 Risk of bacterial infection in COPD patients with Vitamin D defficiency Source: International Congress 2019 – COPD treatment: cohorts and real-world studies Year: 2019 Does vitamin D deficiency worsen the hospital outcome in patients with acute exacerbation COPD? Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD Year: 2018 Relationship between Vitamin D and severity in COPD patients Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care Year: 2017 Persistent chronic cough and vitamin D deficiency Source: Virtual Congress 2021 – New evidence from longitudinal COPD cohorts and other key studies Year: 2021 Vitamin D status by season in patients with advanced pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 64s Year: 2006 Evaluation of vitamin A, E and C supplement therapy on immunologic profiles of pulmonary tuberculosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 455s Year: 2005 Is vitamin D (Vit D) a marker of severity of recurrent wheezing/asthma in infants? Source: Annual Congress 2013 –Preschool wheeze Year: 2013 Late Breaking Abstract: Vitamin D deficiency linked to sepsis in COPD with acute infective exacerbations Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Vitamin D deficiency in acute lung injury (ALI) Source: Annual Congress 2010 - Novel markers of lung injury Year: 2010 Fatigue in sarcoidosis is variable and may be associated to Vitamin D Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage Year: 2019 Protective effects of vitamin D supplementation against acute respiratory infection are greatest in those with the lowest baseline vitamin D status Source: International Congress 2016 – New and old therapies for chronic lung diseases Year: 2016 Serum vitamin C level in patients with acute pneumonia and in COPD patients before and after therapy Source: Eur Respir J 2006; 28: Suppl. 50, 38s Year: 2006 The level of serum vitamin D is a good predictor of prolonged hospitalization in patients with tuberculosis Source: Annual Congress 2010 - Tuberculosis: metabolic insights Year: 2010 Role of vitamin D in asthma severity and control in children Source: Annual Congress 2012 - Clinical and diagnostic markers and management of paediatric allergic diseases Year: 2012